Copyright
©The Author(s) 2024.
World J Stem Cells. Nov 26, 2024; 16(11): 978-984
Published online Nov 26, 2024. doi: 10.4252/wjsc.v16.i11.978
Published online Nov 26, 2024. doi: 10.4252/wjsc.v16.i11.978
Isolation techniques | Key features | ADSC viability | ADSC functionality | Ref. |
Enzymatic digestion (collagenase) | Commonly used method; effectively degrades extracellular matrix components | High initial viability; slight decrease in viability over time because of enzymatic exposure | Promotes adipogenesis and angiogenesis; weakens ADSCs’ immunomodulatory properties through enzymatic exposure | Jeyaraman et al[1], 2024; Garroni et al[13], 2024; Ruoss et al[14], 2024 |
Nonenzymatic mechanical disruption | Utilizes physical methods such as centrifugation and filtration; avoids chemical agents | Generally lower initial viability than that achieved with enzymatic methods; weak effects on long-term cell viability | Maintains multipotency with fewer alterations in the secretome profile; improves preservation of native ADSC functions | Mundluru et al[4], 2024; Goulas et al[11], 2024; Tareen et al[15], 2024 |
Centrifugation-based methods | Separates SVF on the basis of density; often combined with other techniques for enhanced purity | Moderate to high viability; dependent on centrifugation parameters, such as speed and duration | Retains adipogenic and osteogenic potential; weakens immunomodulatory properties through mechanical stress | Jeyaraman et al[1], 2024; Qin et al[5], 2024; Souza et al[6], 2024 |
Microfluidic channel–based isolation | Advanced method utilizing microfluidic channels for precise cell sorting; minimal physical and chemical stress | High viability because of minimal manipulation; enhanced precision in the isolation of ADSCs from SVF | Preserves a wide range of cellular functions, such as differentiation potential and cytokine secretion | Liu et al[2], 2024; Carr et al[3], 2024; Li et al[12], 2024 |
Automated closed systems | Fully automated systems with closed environments to reduce contamination; often used in clinical settings | High viability with reduced contamination risks; consistent and reproducible outcomes | Maintains functional properties, as do traditional methods; improves safety for greater clinical applicability | Soltani et al[8], 2024; Ruoss et al[14], 2024; Mohseni Meybodi et al[16], 2024 |
Hybrid techniques (enzymatic + mechanical) | Combination of enzymatic and mechanical methods to enhance yield and viability | High viability because of the balance between enzymatic efficiency and mechanical preservation of cell integrity | Enhances functional outcomes - for example, by improving differentiation and paracrine effects; allows for tailored applications | Jeyaraman et al[1], 2024; Qin et al[5], 2024; Garroni et al[13], 2024 |
Variables | Description | Ref. |
MSC source | Different tissues (adipose, bone marrow, umbilical cord) produce EVs with different profiles. ADMSCs contain elevated levels of proregenerative factors, such as miRNAs that promote angiogenesis and modulate immune responses | Liu et al[2], 2024; Souza et al[6], 2024 |
Processing protocols | Culture conditions and EV isolation techniques influence EV content and function. Suspension cultures improve EV yield and functionality. Hypoxic preconditioning enhances EVs with tissue repair and immunomodulatory factors | Jeyaraman et al[1], 2024; Suryawan et al[17], 2021 |
Therapeutic efficacy | Therapeutic potential of MSC-derived EVs is associated with their specific compositional profiles. ADMSC-derived EVs are particularly effective in promoting wound healing and modulating immune responses because of their distinct miRNA and protein contents | Soltani et al[8], 2024; Symonds et al[18], 2023 |
Challenges and considerations | Variability in EV composition necessitates careful MSC source selection and standardized processing protocols to optimize therapeutic outcomes. Standardization is essential for producing EVs with consistent therapeutic properties | Liu et al[2], 2024; Carr et al[3], 2024 |
Preconditioning techniques | Clinical outcomes | Future directions | Ref. |
Pharmacological agent use | Increased regenerative capacity; improved immunomodulation | Exploration of novel agents and standardization of therapeutic dosages | Jeyaraman et al[1], 2024; Liu et al[2], 2024 |
Hypoxic preconditioning | Enhanced ADSC survival; improved wound healing | Further investigation for optimizing hypoxia duration and conditions | Suryawan et al[17], 2021 |
Mechanical stimulation | Enhanced tissue regeneration; increased cell viability | Development of standardized protocols for mechanical stimulation | Carr et al[3], 2024; Goulas et al[11], 2024 |
EV modulation | Modulated macrophage polarization; improved anti-inflammatory effects | Investigation of EV content manipulation to optimize therapeutic effects | Souza et al[6], 2024; Symonds et al[18], 2023 |
Chemical preconditioning | Improved angiogenic capacity; accelerated tissue repair | Identification of optimal chemical agents and concentrations | Qin et al[5], 2024; Li et al[12], 2024 |
Cytokine preconditioning | Enhanced immunomodulatory properties; reduced inflammation | Further exploration of cytokine combinations for targeted therapies | Yin and Shen[7], 2024; Yang et al[19], 2024 |
- Citation: Cheng CH, Hao WR, Cheng TH. Refining adipose-derived stem cell isolation for optimal regenerative therapy. World J Stem Cells 2024; 16(11): 978-984
- URL: https://www.wjgnet.com/1948-0210/full/v16/i11/978.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i11.978